Navigation Links
Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
Date:10/31/2007

WESTMINSTER, Colo., Oct. 31 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that Paul L. Berns, President and CEO, will present a corporate overview at the 2007 Acumen BioFin Rodman & Renshaw Conference in New York.

The Company's presentation will take place at 8:50 a.m. (Eastern) on Tuesday, November 6, 2007. There will be a live webcast of the presentation, which will be accessible through a link posted on the Allos website home page and investor relations section. The webcast will be available for replay on Allos' website through November 20, 2007.

About Allos Therapeutics, Inc.

Allos Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer. The Company's lead product candidate, PDX (pralatrexate), is a novel antifolate currently under evaluation in a pivotal Phase 2 (PROPEL) trial in patients with relapsed or refractory peripheral T-cell lymphoma. The PROPEL trial is being conducted under an agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating PDX in patients with non-small cell lung cancer and a range of other lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeutic agent, for which the Company expects to initiate a Phase 1 trial in patients with advanced solid tumors in the fourth quarter of 2007. For additional information, please visit the Company's website at

SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. VBI Provides Potential Targets to Diabetes Therapeutics
2. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
3. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
4. Researchers Present Ways To Reduce The Risk Of Dementia
5. Researchers Present Data Regarding The Efficiency Of Herbs
6. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
7. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
8. Drug Reactions First Present Themselves In The Mouth
9. Reminiscing Into The Past Makes You Dissatisfied With The Present
10. Living In The Past Indicates Dissatisfaction With Present
11. Movies Represent Coma In A Wrong Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 This year, ... Medals, four Special Merit Awards, three Gold Medals and ... projects are described as follows: , (1) Grand Prize ... Robotic Mannequin for Fashion Design and Fitting, Principal Investigator: ... , The apparel industry relies very much on the ...
(Date:5/5/2015)... 2015 Okyanos, the leader in ... The study was conducted to determine the emotional impact ... and sports-related injuries have had on those affected. ... most prevalent symptom reported at 73%, followed by 66% ... and bending over. Over half of respondents, 56%, said ...
(Date:5/5/2015)... Soledad, CA (PRWEB) May 05, 2015 ... just ahead, Josie's Organics, one of the country's ... through the minds of moms across the country. ... through the family recipe box or spend hours ... recipes today on http://www.josiesorganics.com/recipes . , ...
(Date:5/5/2015)... 05, 2015 In the upbeat Moms Helping ... for moms to support each other. Parenting is a ... side makes it so much easier. Mothers talk about ... feel less alone and help them realize there’s no perfect ... Moms who are clearly dear friends share that it's just ...
(Date:5/5/2015)... Los Angeles (PRWEB) May 05, 2015 May ... anniversary of the Institute for Better Bone Health . ... Bone Health aims to educate both consumers and physicians about ... nutritional aspects of bone health. , According to a study ... 54 million total Americans are affected by osteoporosis and low ...
Breaking Medicine News(10 mins):Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3
... at lactate with a much more positive eye, considering ... the immediate //hours after a traumatic brain injury instead ... it could change how emergency room physicians and intensive ... first critical hours after injury. ,Previous work ...
... allergy season in full bloom, the American Academy of Otolaryngology ... what you can do to cope with the pollen in ... can help. // ,This spring, pollen from blooming trees ... million Americans, causing itching eyes, sneezing, nasal stuffiness, nasal congestion ...
... been screened for prostate, colorectal or skin cancer, according to ... has stronger scientific evidence for reducing the risk of death ... study in the Medical Journal of Australia has found that ... other two. ,Dr Monika Janda, a senior ...
... the pulmonary division at National Jewish Medical and Research Center ... before bedtime and asthma medicines in the late afternoon to ... the fact that body behaviour is not the same at ... the circadian rhythms influences allergy and asthma. "Taking your ...
... Hospital in India a new device was being tested on a ... // as the doctor suspects head injury. There could be a ... ,The device the Dr. Alok Sharma is using ... device which uses Near Infrared technology to detect bleeding in the ...
... to several public complaints reported over pharmacists’ and pharmacies refusing ... the Washington State Board of Pharmacy has set out new ... pharmacies and pharmacists are bound to fill the required forms ... to the patient. ,The board was also quoted: ...
Cached Medicine News:Health News:Study Challenges Conventional Treatment of Traumatic Brain Injury 2Health News:April Showers Bring May Flowers – And Plenty of Pollen, To 2Health News:New Invention to Detect Blood Clots 2
(Date:5/5/2015)... Big Market Research presents a detailed analysis of the ... ( France , Germany , ... Japan . Current scientific views on the Hepatitis ... test volume and sales forecasts by country for HAV NAT, HBV ... HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following ...
(Date:5/5/2015)... YORK , May 5, 2015 ... ("E-QURE" or the "Company"), a premier provider of innovative ... treatment, today issued an update to shareholders and the ... the financing and acquisition of the proprietary Bioelectrical Signal ... the completion of its S-1, as well as its ...
(Date:5/5/2015)... , May 5, 2015  The Association of ... of Recognition™ to The Preoperative Stop and Go ... Ph.D. and Mauricio Gonzalez , M.D., anesthesia providers ... Preoperative Stop and Go Sign product is distributed by ... anesthesia management company, and is in compliance with the ...
Breaking Medicine Technology:2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 3
... Arlington Medical Resources (AMR), a provider of premier ... finds that more than half of all European inpatients ... Sanofi-Aventis,s Clexane (marketed as Lovenox in the U.S. and ... The European Hospital Anticoagulant Market Guide is a ...
... 28 Tamir Biotechnology, Inc. (Pink Sheets: ... that scientists supported by the National Institute of ... confirming two of our lead compounds outperformed market ... plaque reduction assay (the gold standard) for Cytomegalovirus ...
Cached Medicine Technology:European Hospital Anticoagulant Market Dominated by Sanofi-Aventis's Clexane 2New Discovery Targets Cytomegalovirus (CMV) 2New Discovery Targets Cytomegalovirus (CMV) 3New Discovery Targets Cytomegalovirus (CMV) 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: